Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation

Thomas Jefferson University

Status: Completed

Conditions: Gastro-esophageal Junction Cancer; Cancer of the Head and Neck; Cancer of the Esophagus; Cancer of the Lung

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00716157

2004-16 (Other Identifier)

1002004024 (Other Grant/Funding Number)

04C.466

Details and patient eligibility

About

Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-nauseous medication prophylaxis.

Full description

Questionnaires will be answered daily on a weekly basis during period of radiation and chemotherapy.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Concurrent radiation and chemotherapy treatment
• Aerodigestive malignancy

Exclusion criteria

• Other causes of vomiting (i.e.gastrointestinal obstruction...)

Trial design

40 participants in 1 patient group

Observation

Description:

Adult patients receiving both radiation therapy and chemotherapy